NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

家禽用疫苗的全球市場:各疾病類型,各技術,各劑型的預測(到2025年)- COVID-19累積的影響

Poultry Vaccine Market Research Report by Disease Type, by Technology, by Dosage Form, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1006113
出版日期 內容資訊 英文 181 Pages
商品交期: 最快1-2個工作天內
價格
家禽用疫苗的全球市場:各疾病類型,各技術,各劑型的預測(到2025年)- COVID-19累積的影響 Poultry Vaccine Market Research Report by Disease Type, by Technology, by Dosage Form, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 181 Pages
簡介

全球家禽用疫苗的市場規模預測將從2020年的16億6,499萬美元,擴大到2025年末的23億1,768萬美元。

COVID-19是前所未有的全球公共衛生突發事件,已影響到每個行業。預計在預測期內,這種長期影響將影響行業增長。我們正在進行的研究正在擴大研究範圍,以確保我們能確實處理潛在的COVID-19問題和未來路徑。該報告提供了對COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場趨勢以及政府的主要干預措施的變化。更新後的調查考慮了COVID-19的市場影響,並提供了見解,分析,預測等信息。

本報告提供全球家禽用疫苗市場的相關調查,提供市場機會和課題,成長及阻礙因素,COVID-19累積的影響,病的種類·技術·劑型·各地區的市場分析,競爭情形,主要企業簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查的成果

第3章 摘要整理

  • 市場展望
  • 各劑型市場展望
  • 各疾病類型市場展望
  • 各技術市場展望
  • 各地區市場的展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各疾病類型市場

  • 傳染性支氣管炎
  • 馬立克病
  • 新城病

第7章 各技術市場

  • 不活化
  • 減毒活病毒疫苗
  • 重組
  • 類毒素

第8章 各劑型市場

  • 導管
  • 冷凍乾燥疫苗
  • 液體

第9章 南北美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區市場

  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章 歐洲,中東·非洲市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 產業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第13章 企業簡介

  • Anicon GmbH
  • Bayer
  • Biovac
  • Biovet Private Limited
  • Boehringer Ingelheim International GmbH
  • CAVAC
  • Ceva Sante Animale
  • ChengDu Tecbond
  • China Animal Husbandry
  • Dechra Pharmaceuticals PLC
  • DHN
  • Elanco
  • Harbin Veterinary Research Institute
  • Hester Biosciences Limited
  • HIPRA
  • Indovax
  • Merck & Co., Inc.
  • MSD & Co. Inc.
  • Phibro Animal Health Corporation
  • Proteon Pharmaceuticals
  • Ringpu Biology
  • Venkys India
  • Venky's Limited
  • Virbac
  • Zoetis Inc.

第14章 附錄

  • 討論指南
  • 許可證和價格
  • 聯絡處詳細內容

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-0375F3EA9C42

The Global Poultry Vaccine Market size was estimated at USD 1,664.99 Million in 2020 and expected to reach USD 1,787.18 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.67% to reach USD 2,595.08 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Poultry Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Disease Type, the Poultry Vaccine Market was studied across Infectious Bronchitis, Marek's Disease, and New Castle Disease.

Based on Technology, the Poultry Vaccine Market was studied across Inactivated, Live Attenuated Vaccines, Recombinant, and Toxoid.

Based on Dosage Form, the Poultry Vaccine Market was studied across Duct, Freeze Dried Vaccines, and Liquid.

Based on Geography, the Poultry Vaccine Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Poultry Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Poultry Vaccine Market, including Anicon GmbH, Bayer, Biovac, Biovet Private Limited, Boehringer Ingelheim International GmbH, CAVAC, Ceva Sante Animale, ChengDu Tecbond, China Animal Husbandry, Dechra Pharmaceuticals PLC, DHN, Elanco, Harbin Veterinary Research Institute, Hester Biosciences Limited, HIPRA, Indovax, Merck & Co., Inc., MSD & Co. Inc., Phibro Animal Health Corporation, Proteon Pharmaceuticals, Ringpu Biology, Venkys India, Venky's Limited, Virbac, and Zoetis Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Poultry Vaccine Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Poultry Vaccine Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Poultry Vaccine Market?
  • 4. What is the competitive strategic window for opportunities in the Global Poultry Vaccine Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Poultry Vaccine Market?
  • 6. What is the market share of the leading vendors in the Global Poultry Vaccine Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Poultry Vaccine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Dosage Form Outlook
  • 3.4. Disease Type Outlook
  • 3.5. Technology Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of animal diseases
      • 5.1.1.2. Surge in awareness on animal vaccination globally
      • 5.1.1.3. Growing need to increase poultry population with demand for animal protein worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of counterfeit medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements for vaccine manufacturing
      • 5.1.3.2. Ongoing aim to increase food safety coupled with favorable government initiatives
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory approval and compliance concerns
      • 5.1.4.2. High cost of veterinary testing and services
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Poultry Vaccine Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Infectious Bronchitis
  • 6.3. Marek's Disease
  • 6.4. New Castle Disease

7. Poultry Vaccine Market, by Technology

  • 7.1. Introduction
  • 7.2. Inactivated
  • 7.3. Live Attenuated Vaccines
  • 7.4. Recombinant
  • 7.5. Toxoid

8. Poultry Vaccine Market, by Dosage Form

  • 8.1. Introduction
  • 8.2. Duct
  • 8.3. Freeze Dried Vaccines
  • 8.4. Liquid

9. Americas Poultry Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Poultry Vaccine Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Poultry Vaccine Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Anicon GmbH
  • 13.2. Bayer
  • 13.3. Biovac
  • 13.4. Biovet Private Limited
  • 13.5. Boehringer Ingelheim International GmbH
  • 13.6. CAVAC
  • 13.7. Ceva Sante Animale
  • 13.8. ChengDu Tecbond
  • 13.9. China Animal Husbandry
  • 13.10. Dechra Pharmaceuticals PLC
  • 13.11. DHN
  • 13.12. Elanco
  • 13.13. Harbin Veterinary Research Institute
  • 13.14. Hester Biosciences Limited
  • 13.15. HIPRA
  • 13.16. Indovax
  • 13.17. Merck & Co., Inc.
  • 13.18. MSD & Co. Inc.
  • 13.19. Phibro Animal Health Corporation
  • 13.20. Proteon Pharmaceuticals
  • 13.21. Ringpu Biology
  • 13.22. Venkys India
  • 13.23. Venky's Limited
  • 13.24. Virbac
  • 13.25. Zoetis Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL POULTRY VACCINE MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL POULTRY VACCINE MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL POULTRY VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2026
  • FIGURE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY INFECTIOUS BRONCHITIS, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL POULTRY VACCINE MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL POULTRY VACCINE MARKET SIZE, BY MAREK'S DISEASE, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL POULTRY VACCINE MARKET SIZE, BY MAREK'S DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL POULTRY VACCINE MARKET SIZE, BY NEW CASTLE DISEASE, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL POULTRY VACCINE MARKET SIZE, BY NEW CASTLE DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
  • FIGURE 18. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2026
  • FIGURE 20. GLOBAL POULTRY VACCINE MARKET SIZE, BY INACTIVATED, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL POULTRY VACCINE MARKET SIZE, BY INACTIVATED, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL POULTRY VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL POULTRY VACCINE MARKET SIZE, BY RECOMBINANT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL POULTRY VACCINE MARKET SIZE, BY TOXOID, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL POULTRY VACCINE MARKET SIZE, BY TOXOID, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2020 VS 2026 (%)
  • FIGURE 29. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2026
  • FIGURE 31. GLOBAL POULTRY VACCINE MARKET SIZE, BY DUCT, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL POULTRY VACCINE MARKET SIZE, BY DUCT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL POULTRY VACCINE MARKET SIZE, BY FREEZE DRIED VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL POULTRY VACCINE MARKET SIZE, BY FREEZE DRIED VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIQUID, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIQUID, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. AMERICAS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 38. AMERICAS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 40. ARGENTINA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. BRAZIL POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. CANADA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. MEXICO POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. UNITED STATES POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. CALIFORNIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. FLORIDA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. ILLINOIS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. NEW YORK POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. OHIO POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. PENNSYLVANIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. TEXAS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 53. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 55. CHINA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. INDIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. INDONESIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. JAPAN POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. MALAYSIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. THAILAND POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 64. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 66. FRANCE POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. GERMANY POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. ITALY POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. QATAR POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. RUSSIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. SPAIN POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. GLOBAL POULTRY VACCINE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 78. GLOBAL POULTRY VACCINE MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 79. GLOBAL POULTRY VACCINE MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL POULTRY VACCINE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL POULTRY VACCINE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL POULTRY VACCINE MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL POULTRY VACCINE MARKET SIZE, BY MAREK'S DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL POULTRY VACCINE MARKET SIZE, BY NEW CASTLE DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY INACTIVATED, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL POULTRY VACCINE MARKET SIZE, BY RECOMBINANT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY TOXOID, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL POULTRY VACCINE MARKET SIZE, BY DUCT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL POULTRY VACCINE MARKET SIZE, BY FREEZE DRIED VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIQUID, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. ARGENTINA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. ARGENTINA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. ARGENTINA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. BRAZIL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. BRAZIL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. BRAZIL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CANADA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CANADA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CANADA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. MEXICO POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. MEXICO POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. MEXICO POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. UNITED STATES POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. UNITED STATES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CALIFORNIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. CALIFORNIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. CALIFORNIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. FLORIDA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. FLORIDA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. FLORIDA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ILLINOIS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ILLINOIS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. ILLINOIS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. NEW YORK POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. NEW YORK POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. NEW YORK POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. OHIO POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. OHIO POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. OHIO POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. PENNSYLVANIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PENNSYLVANIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. PENNSYLVANIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. TEXAS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. TEXAS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. TEXAS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. CHINA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. CHINA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. CHINA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. INDIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. INDIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDONESIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDONESIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. INDONESIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. JAPAN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. JAPAN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. JAPAN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. MALAYSIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. MALAYSIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. MALAYSIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. THAILAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. THAILAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. THAILAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. FRANCE POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. FRANCE POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. FRANCE POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. GERMANY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. GERMANY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. GERMANY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. ITALY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. ITALY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. ITALY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. QATAR POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. QATAR POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. QATAR POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. RUSSIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. RUSSIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. RUSSIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SPAIN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SPAIN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. SPAIN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. GLOBAL POULTRY VACCINE MARKET: SCORES
  • TABLE 123. GLOBAL POULTRY VACCINE MARKET: BUSINESS STRATEGY
  • TABLE 124. GLOBAL POULTRY VACCINE MARKET: PRODUCT SATISFACTION
  • TABLE 125. GLOBAL POULTRY VACCINE MARKET: RANKING
  • TABLE 126. GLOBAL POULTRY VACCINE MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 127. GLOBAL POULTRY VACCINE MARKET: SHARE, BY COMPANY, 2020
  • TABLE 128. GLOBAL POULTRY VACCINE MARKET: MERGER & ACQUISITION
  • TABLE 129. GLOBAL POULTRY VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 130. GLOBAL POULTRY VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 131. GLOBAL POULTRY VACCINE MARKET: INVESTMENT & FUNDING
  • TABLE 132. GLOBAL POULTRY VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 133. GLOBAL POULTRY VACCINE MARKET: LICENSE & PRICING
  • TABLE 134. GLOBAL POULTRY VACCINE MARKET: CONTACT DETAILS